Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 32727
Biomarkers in a Post-Stroke Population: Allied to Health Care in Brazil

Authors: M. Ricardo Lang, A. Costa, I. Iesbik, K. Haag, L. Trindade Buffara, O. Reimann Junior, C. Auswaldt Steclan


Stroke affects not only the individual, but has significant impacts on the social and family context. Therefore, it is necessary to know the peculiarities of each region, in order to contribute to regional public health policies effectively. Thus, the present study discusses biomarkers in a post-stroke population, admitted to a stroke unit (U-stroke) of reference in the southern region of Brazil. Biomarkers were analyzed, such as age, length of stay, mortality rate, survival time, risk factors and family history of stroke in patients after ischemic stroke. In this studied population, comparing men and women, it was identified that men were more affected than women, and the average age of women affected was higher, as they also had the highest mortality rate and the shortest hospital stay. The risk factors identified here were according to the global scenario; with systemic arterial hypertension (SAH) being the most frequent and those associated with sedentary lifestyle in women the most frequent (dyslipidemia, heart disease and obesity). In view of this, the importance of studies that characterize populations regionally is evident, strengthening the strategic planning of policies in favor of health care.

Keywords: Biomarkers, population, stroke, sex, stroke unit.

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 492


[1] V. L. Feigin, et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. The Lancet, 2014, v. 383, n. 9913, p. 245–255, jan.
[2] C.R. Garritano, P.M. Luz, M.L.E. Pires, M.T.S. Barbosa, K.M. Batista. Análise da Tendência da Mortalidade por Acidente Vascular Cerebral no Brasil no Século XXI. Arq Bras Cardiol 2012; 98(6): 519-27.
[3] J. Müller-Nordhorn, K. Wegscheider, C.H. Nolte. Population-based intervention to reduce prehospital delays in patients with cerebrovascular events. Arch Intern Med (Internet). 2009;169: 1484-90.
[4] A. S. Go, et al. Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association. Circulation, 2013, v. 127, n. 1, jan.
[5] G.J. Luvizutto, et al. Characterization of patients treated by rehabilitation service after establishing of an acute stroke unit in a Brazilian hospital. Journal of Physical Therapy Science, 2015, v. 27, n. 8, p. 2533–2536.
[6] T. de S. Botelho, C.D.M. Neto, F.L.C. Araujo de, S.C. Assis de. Epidemiologia do acidente vascular cerebral no Brasil. TemasemSaúde. 2016;16.
[7] S. Northcott, B. Moss, K. Harrison, K. Hilari. A systematic review of the impact of stroke on social support and social networks: associated factors and patterns of change Clin. Rehabil. (2015).
[8] J. L. Saver, Time Is Brain—Quantified. Stroke, 2006, v. 37, n. 1, p. 263–266, jan.
[9] M. El-Koussy, G. Schroth, C. Brekenfeld, M. Arnold Imaging of acute ischemic stroke. Eur. Neurol., 72 (5–6) (2014), pp. 309-316.
[10] M. G. Lansberg, E. Bluhmki, V. N. Thijs. Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic Stroke: A Metaanalysis. Stroke, 2009, v. 40, n. 7, p. 2438–2441, jul.
[11] P. Langhorne, S. Ramachandra. Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) care for stroke: network meta-analysis. Cochrane Database of Systematic Reviews, 2020, 23 abr.
[12] G. Saposnik, O.H. del Bruto. Stroke in South America: A Systematic Review of Incidence, Prevalence, and Stroke Subtypes. Stroke, 2003, v. 34, n. 9, p. 2103–2107, set.
[13] J.J.F. De Carvalho, et al. Stroke Epidemiology, Patterns of Management, and Outcomes in Fortaleza, Brazil: A Hospital-Based Multicenter Prospective Study. Stroke, 2011, v. 42, n. 12, p. 3341–3346, dez.
[14] IBGE.
[15] H. P. Adams, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, v. 24, n. 1, p. 35–41, jan. 1993.
[16] C.D. Bushnell, S. Chaturvedi, K.R. Gage, P.S. Herson, P.D. Hurn, M.C. Jimenez, et al. Sex differences in stroke: Challenges and opportunities. J Cereb Blood Flow Metab. 2018;38:2179–91.
[17] T.S. Olsen, K.K. Andersen. Female survival advantage relates to male inferiority rather than female superiority: A hypothesis based on the impact of age and stroke severity on 1- week to 1-year case fatality in 40,155 men and women. Gend Med. 2010, 7:284-95.
[18] M. Falkenstein, M. Karthaus, U. Brüne-Cohrs.Geriatrics (Basel). 2020. Oct 19;5(4):80.
[19] A.N. Simpkins, M. Janowski, H.S. Oz, J. Roberts, G. Bix, S. Doré, A.M. Stowe. Biomarker Application for Precision Medicine in Stroke. Transl Stroke Res. 2019, Aug;11(4):615-627.
[20] Y. Jiang, K. Sheikh, C. Bullock. Is There a Sex or Race Difference in Stroke Mortality? Journal of Stroke and Cerebrovascular Diseases, 2006, 15(5), 179–186.
[21] E. Boot, M.S. Ekker, J. Putaala, S. Kittner, F.E. De Leeuw, A.M. Tuladhar. J Neurol Neurosurg Psychiatry. 2020. Apr;91(4):411-417.
[22] R. Nugem, R. Bordin, C. Pascal, A.M. Schott-Pethelaz, Trombert-Paviot B, Piriou V, Michel P.J Multidiscip Healthc. 2020 Nov 2;13:1403-1414.
[23] B. Passos de Sá, M. Grave, E. Périco. Profile of patients hospitalized with Stroke in a hospital of Vale do Taquari/RS. Revista Neurociências. 2014;22(03):381-387.
[24] B.N.G. Goulart, C.P.B. Almeida, M.W. Silva, N.S.X. Oenning, V.B. Lagni. Caracterização de acidente vascular cerebral com enfoque em distúrbios da comunicação oral em pacientes de um hospital regional. Audiol Commun Res. 2016. 21:e1603.
[25] A.K. Boehme, C. Esenwa, M.S. Elkind. Stroke Risk Factors, Genetics, and Prevention. Circ Res. 2017. Feb 3;120(3):472-495.
[26] D. Barthels, H. Das. Current advances in ischemic stroke research and therapies. Biochim Biophys Acta Mol Basis Dis. 2020. Apr 1;1866(4):165260.
[27] M.J. O'Donnell, et al. Interstroke investigators. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (Interstroke): a case-control study. Lancet. 2016. Aug 20;388(10046):761-75.
[28] K.I. Gallacher, R. McQueenie, B. Nicholl, et al. Risk factors and mortality associated with multimorbidity in people with stroke or transient ischaemic attack: a study of 8,751 UK Biobank participants. J Comorbid, 8 (2018), pp. 1-8.
[29] A. Guzik, C. Bushnell. Stroke Epidemiology and Risk Factor Management. Continuum (Minneap Minn). 2017. Feb;23(1, Cerebrovascular Disease):15-39.
[30] V.A. Hill, A. Towfighi. Modifiable Risk Factors for Stroke and Strategies for Stroke Prevention. Semin Neurol. 2017 Jun;37(3):237-258.
[31] K. Furie. Epidemiology and Primary Prevention of Stroke. Continuum (Minneap Minn). 2020. Apr;26(2):260-267.